Number of shares under non-option equity instrument agreements for which rights to exercise lapsed.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(04)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

STOCKHOLDERS DEFICIENCY (Details 3) - shares	3 Months Ended	12 Months Ended
STOCKHOLDERS DEFICIENCY (Details 3) - shares	Sep. 30, 2024	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2021
STOCKHOLDERS DEFICIENCY
Outstanding at beginning of year	1,374,980
Granted		264,945	238,838	60,566	95,167
Vested	(232,941)
Expirations	(2,726)
Outstanding at ending of year	1,139,313	1,374,980